Ze-kun- Deng

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

Zheng Wang, Si-qi Qiu, Yuan-ke Liang, 2021, Frontiers in Oncology.

Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury

Yinhuai Wang, Ze-kun- Deng, Hao-ye Zhang, 2022, BioMed research international.

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Hui Meng, Jian Zhang, P. Luo, 2021, Frontiers in Immunology.

WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury

Z. Dong, F. Deng, Yingbo Dai, 2023, Redox biology.

Identification of TACSTD2 as novel therapeutic targets for cisplatin-induced acute kidney injury by multi-omics data integration.

F. Deng, Ze-kun- Deng, Zheng Dong, 2024, Human genetics.

CHIP protects against septic acute kidney injury by inhibiting NLRP3-mediated pyroptosis

Y. Kanwar, F. Deng, Yingbo Dai, 2023, iScience.

Exploration of the prognostic effect of costimulatory genes in bladder cancer

Ze-kun- Deng, Xiaozhe Su, Yinhuai Wang, 2024, The journal of gene medicine.

PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin‐induced acute kidney injury

F. Deng, Ze-kun- Deng, Lizhi Zhou, 2024, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.